Connable Office Inc’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,409
| Closed | -$263K | – | 211 |
|
|
2022
Q1 | $263K | Buy |
+6,409
| New | +$263K | 0.04% | 187 |
|
|
2021
Q4 | – | Sell |
-6,122
| Closed | -$307K | – | 224 |
|
|
2021
Q3 | $307K | Buy |
6,122
+1,739
| +40% | +$87.2K | 0.04% | 173 |
|
|
2021
Q2 | $276K | Hold |
4,383
| – | – | 0.04% | 180 |
|
|
2021
Q1 | $407K | Sell |
4,383
-267
| -6% | -$24.8K | 0.06% | 154 |
|
|
2020
Q4 | $417K | Sell |
4,650
-287
| -6% | -$25.7K | 0.06% | 144 |
|
|
2020
Q3 | $510K | Sell |
4,937
-4,851
| -50% | -$501K | 0.1% | 113 |
|
|
2020
Q2 | $774K | Buy |
9,788
+1,009
| +11% | +$79.8K | 0.15% | 88 |
|
|
2020
Q1 | $508K | Buy |
8,779
+3,252
| +59% | +$188K | 0.12% | 89 |
|
|
2019
Q4 | $298K | Hold |
5,527
| – | – | 0.05% | 143 |
|
|
2019
Q3 | $289K | Buy |
5,527
+109
| +2% | +$5.7K | 0.05% | 139 |
|
|
2019
Q2 | $262K | Buy |
+5,418
| New | +$262K | 0.05% | 147 |
|